1. Home
  2. CRTO vs ZLAB Comparison

CRTO vs ZLAB Comparison

Compare CRTO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Criteo S.A.

CRTO

Criteo S.A.

HOLD

Current Price

$17.14

Market Cap

923.5M

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$24.79

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRTO
ZLAB
Founded
2005
2013
Country
France
China
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.5M
2.6B
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
CRTO
ZLAB
Price
$17.14
$24.79
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$34.00
$49.60
AVG Volume (30 Days)
321.5K
942.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
38.95
38.46
EPS
0.37
N/A
Revenue
$2,296,692,000.00
$460,156,000.00
Revenue This Year
N/A
$9.75
Revenue Next Year
$5.54
$26.03
P/E Ratio
$47.14
N/A
Revenue Growth
27.65
15.33
52 Week Low
$15.58
$15.96
52 Week High
$25.29
$34.72

Technical Indicators

Market Signals
Indicator
CRTO
ZLAB
Relative Strength Index (RSI) 42.55 50.08
Support Level $16.57 $16.84
Resistance Level $18.24 $25.28
Average True Range (ATR) 0.56 0.81
MACD 0.08 -0.45
Stochastic Oscillator 29.27 24.35

Price Performance

Historical Comparison
CRTO
ZLAB

About CRTO Criteo S.A.

Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: